Profil
Jeffrey Greve is the founder of Delinia, Inc. (founded in 2015) and Kyverna Therapeutics, Inc. (founded in 2018).
At Delinia, he held the title of Chief Scientific Officer.
At Kyverna Therapeutics, he held the title of Chief Scientific Officer from 2018 to 2022.
Dr. Greve's former job was as Vice President-Research at aTyr Pharma, Inc. Dr. Greve earned a doctorate degree from the University of Washington and an undergraduate degree from The Johns Hopkins University.
Ehemalige bekannte Positionen von Jeffrey Greve
| Unternehmen | Position | Ende |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Gründer | 23.08.2022 |
Delinia, Inc.
Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Gründer | - |
| ATYR PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jeffrey Greve
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delinia, Inc.
Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
















